Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session

Zacks

Flexion Therapeutics, Inc. (FLXN) was a big mover last session, as its shares rose nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the flattish trend of $12.45 to $13.03 in the past one-month time frame.
 
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
 
Flexion Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
 
Other better-ranked stocks in the Med-drugs industry include Aeolus Pharmaceuticals Inc. (AOLS), Aerie Pharmaceuticals, Inc. (AERI) and Ariad Pharmaceuticals Inc. (ARIA). All these stocks carry a Zacks Rank #2 (Buy).
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



FLEXION THERAPEUTICS INC (FLXN): Free Stock Analysis Report

AERIE PHARMACEUTICALS INC (AERI): Free Stock Analysis Report

AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report

ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)